×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Dr. Mike Roizen
Dr. Mike Roizen is chief medical officer at the Cleveland Clinic Wellness Institute, an award-winning author, and has been the doctor to eight Nobel Prize winners and more than 100 Fortune 500 CEOs.

Dr. Mike Roizen

Tags: yeast infection | candida | diabetes | dr. roizen

New Treatment for Chronic Yeast Infections

Michael Roizen, M.D. By Friday, 27 May 2022 12:17 PM EDT Current | Bio | Archive

When you think of yeast, you might imagine the microorganisms that make bread dough rise (there are more than 200 billion in a packet of dry yeast).

But there are other forms of yeast that live in the human body, helping your digestive and immune systems function and assisting in the absorption of vitamins and minerals from food. Sometimes they get thrown out of balance. When that happens in the vagina, a yeast called Candida causes a condition known as vaginal candidiasis.

This infection is common — an estimated 1.4 million outpatient visits for vaginal candidiasis happen annually in the U.S.

Sometimes because of medications (oral and inhaled corticosteroids and immunosuppressive drugs), chronic health conditions (diabetes, for example), or lifestyle habits (wearing sweaty, tight gym clothes, douching), the infections become chronic, occurring three or more times a year. That is called recurrent vulvovaginal candidiasis (RVVC).

Nearly 75% of adult women experience one yeast infection in their lifetime; approximately half experience a recurrence; and up to 9% of those women develop RVVC.

Until now, there's been no medication specifically targeting chronic candidiasis. But recently the Food and Drug Administration approved the first-ever drug  that treats RVVC, called oteseconazole.

In two studies, 93.3% and 96.1% of women with RVVC who received the treatment didn't experience a recurrence during a 48-week maintenance period.

But — and there's always a but — it's only for postmenopausal women or those who are permanently infertile, because it is embryo-fetal toxic.

However, if you suffer with RVVC and meet those criteria, talk to your doctor about the benefits and risks of this long-awaited treatment.

© King Features Syndicate


DrRoizen
Nearly 75% of adult women experience one yeast infection in their lifetime; approximately half experience a recurrence; and up to 9% of those women develop recurrent vulvovaginal candidiasis.
yeast infection, candida, diabetes, dr. roizen
264
2022-17-27
Friday, 27 May 2022 12:17 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved